Bibliographic Details
| Title: |
A Phase I Study of Gemtuzumab Ozogamicin in Combination With a Myeloablative Conditioning (MAC) Regimen and alloSCT in Children With High-Risk CD33+ AML: A New Targeted Immunochemotherapy Conditioning Regimen (GO-BU/CY) |
| Authors: |
Satwani, P.1, Dela Cruz, F.1, Le Gall, J.1, Jin, Z.1, Bhatia, M.1, Garvin, J.H.1, George, D.1, Schwartz, J.1, van de Ven, C.1, Morris, E.1, Baxter-Lowe, L.A.2, Cairo, M.S.1 |
| Source: |
Biology of Blood & Marrow Transplantation. Feb2011 Supplement, Vol. 17 Issue 2, pS247-S247. 1p. |
| Database: |
Academic Search Ultimate |
